Addiction Professional 2007;5(5):26-31.
Timothy P. Condon, PhD (National Institute on Drug Abuse (NIDA)).
To assess the practical effectiveness of proven treatments, NIDA uses as one of its tools the National Drug Abuse Treatment Clinical Trials Network. The CTN involves practitioners from community-based treatment programs in formulating research protocols, trains them to implement and assess the various research-based therapies under study, and elicits feedback on treatment success and feasibility. Training community providers to deliver research-based treatments is a driving force for their use with patients. It also facilitates a continuous improvement loop whereby practitioners identify products needed by the field, then participate in testing and adapting them as necessary. Developing implementation tools for research-based practices and putting them into the hands of treatment professionals is, of course, a key component of creating the change NIDA is helping to bring about.
Blending Teams, composed of NIDA researchers, community treatment practitioners, and representatives from SAMHSA's Addiction Technology Transfer Center (ATTC) program (which NIDA partially supports), create products designed to foster adoption of new research-based treatment strategies. The ATTCs, a network of 14 regional offices and a national office, monitor, translate, and disseminate advances in addiction research, and provide treatment professionals with assistance to enhance needed skills. This article describes two of the Blending Initiative products based on research done in the CTN about buprenorphine detoxification and motivational incentives. The development of new Blending products is a truly dynamic one that does not wait for research results to be published in peer-reviewed journals, with the hazy hope of eventual translation to practical application. Instead, for the first time, science-based products are being made available at nearly the same time that research results are published. Through the mutually beneficial exchange of knowledge and experience between research and practice, the NIDA/SAMHSA-ATTC Blending Initiative ultimately will improve the export of treatments from bench to bedside to community -- it is not just bridging the gap between research and practice, but closing it. (Magazine article, HTML, English, 2007)
Keywords: Adoption of interventions | Blending Team Product | Buprenorphine | Buprenorphine/Naloxone | Community health services information | Contingency Management (CM) | CTN research agenda | Dissemination | National Drug Abuse Treatment Clinical Trials Network | Motivational incentives | Opioid dependence | Opioid detoxification | Pharmacological therapy | Suboxone | Subutex | Addiction Professional (magazine)
Document No: 246
Submitted by CTN Dissemination Librarians, 10/19/2007.